Health Condition 1: null- 15-45yrs women with heavy menstrual bleeding
Conditions
Interventions
Intervention1: Combined vaginal rings: CVR which releases 15μg ethinyl estradiol and 120 μg etonogesterol daily will be inserted in the vagina on the fifth day of the cycle, for next three weeks. A
Sponsors
Department of Obst Gynae Armed Forces Medical CollegeAFMC Pune Maharashtra India
Eligibility
Inclusion criteria
Inclusion criteria: Women included will be in reproductive age group of 15-45 years with complaint of heavy menstrual bleeding. Women with fibroids
Exclusion criteria
Exclusion criteria: i) Women having no contraindication to steroid contraceptives like medical disorders Eg: jaundice, migraine, epilepsy, hypertension or diabetes mellitus, history of thromboembolism, breast or genital tract malignancy, genital prolapse or infections. ii) Conditions relevant to CVR such as cervicitis, vaginitis, cervical erosion, dyspareunia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of menstrual blood loss by Pictorial Blood Loss Assessment Chart (PBAC). Menstrual cycle pattern & duration of flow Change in hemoglobin Timepoint: 3months | — |
Secondary
| Measure | Time frame |
|---|---|
| Side-effects, Acceptability Timepoint: 3months | — |
Countries
India
Contacts
Public ContactDr Meenakshi K Bharadwaj
armed forces medical college
Outcome results
None listed